These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 12933699)

  • 1. Cyclic GMP phosphodiesterases and regulation of smooth muscle function.
    Rybalkin SD; Yan C; Bornfeldt KE; Beavo JA
    Circ Res; 2003 Aug; 93(4):280-91. PubMed ID: 12933699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
    Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
    Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells.
    Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR
    Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivity.
    Turko IV; Francis SH; Corbin JD
    Biochemistry; 1998 Mar; 37(12):4200-5. PubMed ID: 9521742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects.
    Werkström V; Svensson A; Andersson KE; Hedlund P
    BJU Int; 2006 Aug; 98(2):414-23. PubMed ID: 16626307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
    Geng Y; Zhou L; Thompson WJ; Lotz M
    J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and regulation of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) in human colonic epithelial cells: role in the induction of cellular refractoriness to the heat-stable enterotoxin peptide.
    Bakre MM; Sopory S; Visweswariah SS
    J Cell Biochem; 2000 Feb; 77(1):159-67. PubMed ID: 10679826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
    Ghalayini IF
    Int J Impot Res; 2004 Dec; 16(6):459-69. PubMed ID: 15229623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.
    Rybalkin SD; Rybalkina IG; Shimizu-Albergine M; Tang XB; Beavo JA
    EMBO J; 2003 Feb; 22(3):469-78. PubMed ID: 12554648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages.
    Witwicka H; Kobiałka M; Siednienko J; Mitkiewicz M; Gorczyca WA
    Biochim Biophys Acta; 2007 Feb; 1773(2):209-18. PubMed ID: 17141339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.
    Kim D; Rybalkin SD; Pi X; Wang Y; Zhang C; Munzel T; Beavo JA; Berk BC; Yan C
    Circulation; 2001 Nov; 104(19):2338-43. PubMed ID: 11696475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
    Piazza GA; Thompson WJ; Pamukcu R; Alila HW; Whitehead CM; Liu L; Fetter JR; Gresh WE; Klein-Szanto AJ; Farnell DR; Eto I; Grubbs CJ
    Cancer Res; 2001 May; 61(10):3961-8. PubMed ID: 11358813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of SNAP potentiating antiproliferative effect of calcitonin gene-related peptide in cultured vascular smooth muscle cells.
    Wang X; Wang W; Li Y; Bai Y; Fiscus RR
    J Mol Cell Cardiol; 1999 Sep; 31(9):1599-606. PubMed ID: 10471344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular implications in the use of PDE5 inhibitor therapy.
    Maurice DH
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S20-3. PubMed ID: 15224131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development.
    Sanchez LS; de la Monte SM; Filippov G; Jones RC; Zapol WM; Bloch KD
    Pediatr Res; 1998 Feb; 43(2):163-8. PubMed ID: 9475279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation.
    Mullershausen F; Russwurm M; Koesling D; Friebe A
    Mol Biol Cell; 2004 Sep; 15(9):4023-30. PubMed ID: 15240816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.